Literature DB >> 22385409

Expression of bone morphogenetic protein 2, 4, 5, and 7 correlates with histological activity of otosclerotic foci.

Péter Csomor1, Balázs Liktor, Bálint Liktor, Zoltán Szekanecz, István Sziklai, Tamás Karosi.   

Abstract

CONCLUSION: This study is the first to establish that bone morphogenetic protein 5 (BMP5) plays a role in the pathogenesis of otosclerosis. These results confirm that elevated expression levels of BMPs, members of the transforming growth factor (TGF)-β superfamily, contribute to the pathologically increased bone turnover in early, active stages of otosclerosis.
OBJECTIVES: Otosclerosis is a complex bone remodeling disorder of the otic capsule, which might be characterized by increased expression of different types of BMPs. TGF-β and BMP are both members of the TGF-β superfamily and play a critical role in bone resorption and new bone formation. It has been suggested that BMP and its receptors may be involved in the pathologically increased bone turnover observed in otosclerosis.
METHODS: Fifty-one otosclerotic and 16 non-otosclerotic ankylotic stapes footplates were histologically analyzed: conventional hematoxylin-eosin staining and BMP2, 4, 5, and 7specific immunofluorescent assays were performed. Cortical bone fragments (n = 35) and incus specimens (n = 6) were used as negative controls.
RESULTS: Active otosclerosis (n = 39) was characterized by increased expression of BMP2, 4, 5, and 7. Inactive cases of otosclerosis (n = 12) were characterized by negative immunoreaction for BMPs. Non-otosclerotic stapes specimens (n = 16) and negative controls (n = 41) showed negligible BMP expression. The BMP expression pattern showed a strong correlation with the histological activity of otosclerosis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22385409     DOI: 10.3109/00016489.2011.653669

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  5 in total

1.  Identification of target proteins involved in cochlear otosclerosis.

Authors:  Céline Richard; Joni K Doherty; Jose N Fayad; Ana Cordero; Fred H Linthicum
Journal:  Otol Neurotol       Date:  2015-06       Impact factor: 2.311

2.  Computed Tomography Density as a Bio-marker for Histologic Grade of Otosclerosis: A Human Temporal Bone Pathology Study.

Authors:  Alicia M Quesnel; Reuven Ishai; Timothy Meehan; Jennifer T O'Malley; Renee Mitchell; Jennifer J Shin; Hugh D Curtin; Joseph B Nadol; Michael J McKenna; Amy F Juliano
Journal:  Otol Neurotol       Date:  2022-07-01       Impact factor: 2.619

Review 3.  Perspectives of pharmacological treatment in otosclerosis.

Authors:  Balázs Liktor; Zoltán Szekanecz; Tamás József Batta; István Sziklai; Tamás Karosi
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-07-29       Impact factor: 2.503

4.  The lack of 4-hydroxynonenal in otosclerotic bone tissue in Ethiopian population.

Authors:  Milan Rudic; Richard Wagner; Eric Willkinson; Giovanni Danese; Nega Kiros; Kamelija Zarkovic; Neven Zarkovic
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-09-14       Impact factor: 2.503

5.  Evaluation of the association between a single-nucleotide polymorphism of bone morphogenetic proteins 5 gene and risk of knee osteoarthritis.

Authors:  A C Sharma; R N Srivastava; S R Srivastava; A Agrahari; A Singh; D Parmar
Journal:  J Postgrad Med       Date:  2017 Jul-Sep       Impact factor: 1.476

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.